BRAT1 and glioblastoma: Lastly, we describe the BRAT1 inhibitor CurD as a putative drug candidate specifically targeting BRAT1, which partially increases radiosensitivity of GBM, thereby opening new perspectives for the development of targeted GBM therapy.